Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

NCT00268593 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: PI-88
DRUG: docetaxel
DRUG: prednisone

Sponsor

Progen Pharmaceuticals

Collaborators

[object Object]
[object Object]